Trial site
Prolato Clinical Research Center
- 22running trials
- 11closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy11 trials
- Lupus (SLE)7 trials
- Chronic kidney disease5 trials
- Gout2 trials
- Polymyalgia rheumatica2 trials
- Rheumatoid arthritis2 trials
- Sjögren's disease2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Giant cell arteritis1 trial
- Lewy body dementia1 trial
- Long COVID and ME/CFS1 trial
- Myasthenia gravis1 trial
- and 4 more
- Phase
- Phase 317 trials
- Phase 29 trials
- Phase 14 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Active, not recruiting13 trials
- Recruiting8 trials
- Completed7 trials
- Terminated2 trials
- Withdrawn2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Novartis Pharmaceuticals10 trials
- Biogen2 trials
- Crystalys Therapeutics2 trials
- Hoffmann-La Roche2 trials
- ACADIA Pharmaceuticals Inc.1 trial
- and 16 more
Running trials
Recruiting
Recruiting
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Recruiting
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Active, not recruiting
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- IgA nephropathy3 recruiting
- Gout2 recruiting
- Lupus (SLE)2 recruiting
- Lewy body dementia1 recruiting
- Nephrotic syndrome1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Completed
Terminated
Completed
Withdrawn
A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria
Terminated
Completed
Recruiting
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
Site data: ClinicalTrials.govUpdated 15 Nov 2026